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Testing and Reducing Skindex-29 Using Rasch
Analysis: Skindex-17
Tamar E.C. Nijsten1, Francesca Sampogna2, Mary-Margaret Chren3 and Damiano D. Abeni2
The Skindex is a well-studied dermatology-specific health-related quality of life (HRQOL) instrument. The
objective of this study was to test Skindex-29 using Rasch analysis and, if necessary, to refine it so that it would
fit this item response theory based model. The Skindex-29 of 454 Italian dermatological patients was subjected
to Rasch analysis to investigate threshold order, differential item functioning (DIF), and item and overall fit to
the model. The Skindex-29 did not fit the Rasch model (Po0.001). The 5-point scoring system was re-grouped
into three categories and demonstrated logical response order for all but one item. Rasch analyses of a
combined emotion and social functioning subscale of Skindex-29 resulted in a 12-item psychosocial subscale.
Five of seven items were retained in a symptoms subscale. Both subscales fitted the model (P¼ 0.32 and 0.13,
respectively) without significant individual item misfit or DIF (P40.05). Classical psychometric properties such
as response distribution, item–rest correlation, item complexity, and internal consistency of the two subscales of
Skindex-17 were at least adequate. The Skindex-17 is a Rasch reduced version of Skindex-29, with two
independent scores that can be used in the measurement of HRQOL in dermatological patients.
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INTRODUCTION
The Skindex is a health-related quality of life (HRQOL)
instrument designed to measure the effects of skin disease on
patients’ lives. This dermatology-specific questionnaire has
been extensively studied and refined in different population
samples (Chren et al., 1996, 1997; Abeni et al., 2002;
Augustin et al., 2004). Although the original Skindex
consisted of 61 items (Chren et al., 1996), a refinement study
demonstrated that Skindex-29 decreased respondent burden
and improved its discriminative and evaluative capability
(Chren et al., 1997). The methodology in both the original
and the refinement study was based on classical test theory to
retain or discard items.
For decades, classical test theory has been the most
commonly used approach to create and reduce patient-based
assessments, and includes multiple psychometric features
(Chren, 1999; Guyatt et al., 2002; Nijsten et al., 2006).
Although classical test theory has been proven to be a valid
and reliable methodology and there is no consensus of how
to reduce existing HRQOL instruments (Coste et al., 1997;
Prieto et al., 2003; Nijsten et al., 2006), this approach is
unable to solve some fundamental measurement issues such
as response order (i.e., logical ordering of the response
categories), additivity, which requires unidimensionality of
the measurement, and differential item functioning (DIF)
(assessing the effect of external factors, including diagnosis,
on item response) (McHorney, 1997; Michell, 2003; Tesio,
2003; Tennant et al., 2004a).
Recently, item response theory-based models such as the
Rasch model have become widely available, which should
encourage psychometric research to address some of these
fundamental measurement issues (Rasch, 1960; McHorney,
1997; Michell, 2003; Streiner and Norman, 2003; Tennant
et al., 2004a). Basically, these models attempt to ensure
the transition from representational (nominal, ordinal, inter-
val, and ratio scales) (Stevens, 1946) to fundamental
measurement (i.e., weight (g), distance (m), or temperature
1C) (Michell, 1997, 2003; Chren, 2005). This transition is
important because it allows investigators to calculate mean
scores and change of scores without the restrictions
associated with nonparametric, representational measure-
ment. Rasch analysis is one among the most commonly used
item response theory models to create new or test existing
HRQOL instruments (Tennant et al., 2004a).
The overall goal of this work was to use item response
theory to examine the responses to Skindex-29 of a large
sample of patients. In this study, we used the Rasch model to
test threshold order, item fit, and DIF. In addition, we aspired
to create a reduced version of this instrument that fitted the
Rasch model and behaved psychometrically well among
a heterogenous group of dermatological patients.
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RESULTS
Study population
The majority of the 454 patients were young to middle-aged
women (Table 1). More than 60% of the participants were
diagnosed with an inflammatory skin disease such as acne,
psoriasis, and seborrheic dermatitis, and almost half of the
patients were graded as having at least moderate disease
severity. No significant differences of demographic or disease
characteristics were detected between the two random
samples of the study population.
Rasch analysis
Threshold order for all items. The threshold of the original
5-point scoring system of Skindex-29 was significantly
disordered for all 29 items in sample 1. For example, the
probability that a person with little HRQOL impairment
scored 0 was superior to that of scoring 1, which is defined as
threshold order, but those with little impairment were more
likely to score 2 than 1, which is defined as threshold
disorder, for item 24 (Figure 1). The order between 2, 3, and 4
appeared to be logical for this item. In fact, the category
probability curves demonstrated a disordered pattern bet-
ween 1 and 2 for all items. In addition, 20 of 29 items
(69.0%) showed a logical transition between response
category 2 and 3 and 25 of 29 (86.2%) items had a good
transition between category 3 and 4. However, re-grouping
the original Skindex scores into 0 (0), 1 (1 and 2), and 2 (3)
and 3 (4) demonstrated reversed thresholds in 8 of the 29
items. To avoid creating individual scoring systems for these
items or deleting them from the reduced instrument, the
original response categories were re-grouped into three
levels, as 0 (0), 1 (1 and 2), and 2 (3 and 4), which resulted
in ordered thresholds for all items, except item 30.
Individual item fit and DIF for the psychosocial subscale.
Although item 30 was the first to be discarded due to reversed
thresholds, it also misfitted the Rasch model (P¼0.01)
and demonstrated DIF for age (P¼ 0.03) and diagnosis
(P¼0.0005). Each of the other eight items that were deleted
demonstrated significant item misfit in the Rasch model
(Pp0.02), except for item 12, which demonstrated significant
DIF for both age (P¼ 0.008) and gender (P¼ 0.003). Items 2
and 19 showed significant DIF for diagnosis and item 2 for
age (Pp0.006). Items 3, 9, 13, 15, and 19 were primarily
discarded because they misfitted the Rasch model.
Overall, the 12 remaining items of the psychosocial
subscale fitted the Rasch model well (total-item w2¼39.45,
df¼36, and P¼0.32) (Table S1). After removing the ‘‘Rasch
factor’’, a principal component analysis demonstrated that
the first component accounted for only 16.3% of the
variance.
Individual item fit and DIF for the symptoms subscale.
Although the overall fit for the seven symptoms-related items
was acceptable (total-item w2¼ 40.28, df¼35, and P¼0.13),
item 24 was deleted due to significant DIF for gender
(Po0.001) and age (P¼0.02). Subsequently, item 7 misfitted
the model (residual¼1.40 and P¼0.01) and was discar-
ded. The remaining items showed a good overall fit to the
Rasch model (total-item w2¼29.31, df¼25, and P¼0.25)
(Table S2). After extracting the Rasch factor, the second factor
only reflected 27.7% of the variance of this subscale.
Validation of Rasch analyses
The items retained in the analyses using sample 1 (presented
data) or 2 were comparable, except that the validation
Table 1. Demographic and disease characteristics of
the study population1
Total (n=454)
No. of
patients (%)
Sample 1
(n=227) No. of
patients (%)
Sample 2
(n=227) No. of
patients (%)
Gender
Female 270 (59.7) 131 (57.7) 139 (61.7)
Male 182 (40.3) 96 (42.3) 86 (38.2)
Age (years)
o45 225 (49.8) 110 (48.9) 115 (51.1)
45–65 162 (35.8) 86 (37.9) 76 (33.8)
465 65 (14.4) 31 (13.7) 34 (15.1)
Diagnosis
Acne 151 (33.3) 73 (32.2) 78 (34.4)
Psoriasis 76 (16.7) 40 (17.6) 36 (15.9)
Seborrheic
dermatitis
54 (12.0) 27 (11.9) 27 (11.9)
Alopecia
areata
46 (10.2) 25 (11.0) 21 (9.3)
Vitiligo 27 (6.0) 13 (5.7) 14 (6.2)
Nevi 100 (21.7) 49 (21.6) 51 (22.5)
Physician global assessment
Very mild 64 (14.2) 30 (13.2) 34 (15.0)
Mild 160 (35.4) 87 (38.3) 73 (32.2)
Moderate 189 (41.8) 97 (42.7) 92 (40.5)
Severe/very
severe
31 (6.9) 13 (5.7) 18 (7.9)
1Totals may vary because of missing values.
1.0
0.5
0.0
–3 –2 –1 0
Person location (logits)
1 2 3
Pr
ob
ab
ilit
y
0
1
2 3
4
Figure 1. The category probability curve for item 24 (‘‘sensitive skin’’)
(n¼ 454).
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sample did not reject item 2 in the psychosocial and 7 in the
symptoms subscale. The overall summary fit statistics of both
groups of patients were nonsignificant (P¼0.32 vs 0.16 and
P¼0.25 vs 0.12 for the psychosocial and symptoms subscale,
respectively), with similar Cronbach’s a’s (0.81 vs 0.83 and
0.77 vs 0.78 for the psychosocial and symptoms subscales,
respectively). Also, both Rasch reduced subscales captured
more than 85% of the total variance of the original Skindex-
29. Adding item 2 to the retained psychosocial items of
sample 1 resulted in a poor fit to the Rasch model (P¼0.002
and item 2 showed item significant misfit and DIF for age)
and adding item 7 to the symptoms items of sample 1 resulted
in borderline overall fit (P¼ 0.06), but with individual item
misfit. Therefore, items 2 and 7 were not included in the
final Rasch reduced Skindex, which we named Skindex-17
(Appendix S2).
Classical psychometric properties of Skindex-17
Validity of Skindex-17. The face validity of Skindex-17
appeared to be adequate because it distinguished symptoms
from functioning and emotions, which are likely to show
some extent of overlap. As hypothesized, patients with acne,
psoriasis, and seborrheic dermatitis reported significantly
higher scores for both subscales of Skindex-17 than nevi
patients (Po0.001) (Table S3). The new Skindex-17 subscales
correlated very well to excellent with Skindex-29 and its
original corresponding subscales (rX0.83). The items of
Skindex-17 of both subscales represented 94% of the vari-
ance of the total score of Skindex-29 (adjusted R2¼0.94).
Both new subscales captured at least 87% of the variance
of their original Skindex-29 subscales (adjusted R2 scores of
the psychosocial items were 0.95 and 0.87 for functioning
and emotions, respectively, and 0.87 of the reduced
symptoms subscale compared to its original version).
Item behaviour of Skindex-17. Of the 12 items of the psycho-
social subscale, five items (8, 14, 17, 24, and 27) showed a
suboptimal response distribution with more than 70% of the
514 participants who scored ‘‘0’’. The ‘‘floor’’ effect of these
items disappeared after deleting the 100 patients with nevi
(21.6% of the total study population). The correlation
coefficients between the 12 items of the psychosocial
subscale ranged from 0.31 to 0.64 and for the symptom
subscale from 0.33 to 0.57. Each of the retained items
correlated moderately (rX0.40), with at least one other item
in its subscale (data not shown) suggesting item redundancy.
For both subscales, the Cronbach’s a’s were X0.70 for the
items and the item–rest correlation coefficients were X0.35,
suggesting good internal consistency and reasonable ‘‘homo-
geneity’’ (Table 2). None of the items of the psychosocial
subscale correlated equally or stronger for the symptoms
subscale and vice versa, which indicates good item discrimi-
Table 2. Classical psychometric properties of the Skindex-17 (n=454)1
Factor analysis2
Items
Factor 1, psychosocial
subscale (eigenvalue=4, 7)
Factor 2, symptom subscale
(eigenvalue=1, 5) Uniqueness Crohnbach’s a
Item–rest
correlation
4 ‘‘work or hobbies’’ 0.61 0.41 0.39 0.93 0.67
5 ‘‘social life’’ 0.79 0.23 0.26 0.92 0.80
6 ‘‘depressed’’ 0.64 0.27 0.43 0.93 0.66
8 ‘‘stay at home’’ 0.74 0.19 0.36 0.93 0.72
11 ‘‘closeness with loved ones’’ 0.74 0.26 0.34 0.92 0.75
14 ‘‘do things by themselves’’ 0.65 0.25 0.42 0.92 0.67
17 ‘‘showing affection’’ 0.69 0.21 0.39 0.93 0.70
21 ‘‘embarrassed’’ 0.73 0.25 0.30 0.92 0.73
23 ‘‘frustrated’’ 0.75 0.15 0.35 0.93 0.73
25 ‘‘desire to be with people’’ 0.83 0.09 0.29 0.93 0.78
26 ‘‘humiliated’’ 0.72 0.08 0.39 0.93 0.68
29 ‘‘sex life’’ 0.57 0.12 0.60 0.93 0.56
1 ‘‘hurts’’ 0.42 0.54 0.49 0.74 0.52
10 ‘‘itches’’ 0.09 0.67 0.51 0.72 0.55
16 ‘‘bothered by water’’ 0.14 0.43 0.72 0.78 0.40
19 ‘‘irritated’’ 0.33 0.58 0.53 0.72 0.57
27 ‘‘bleeding’’ 0.20 0.77 0.35 0.70 0.35
1Except for factor analysis, the analyses were performed for the psychosocial and symptom subscales separately.
2Principal component analysis followed by orthogonal rotation. Factors were retained if eigenvalue41.
Bold values indicate loadings X0.40.
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nant validity (data not shown). Factor analysis of Skindex-17
confirms its two-dimensional structure and separates the
psychosocial from the symptoms subscale (Table 2). Items 1
and 4 demonstrate moderate item complexity because their
loadings are X0.40.
Categorization of Skindex-17
For both subscales we performed mixture analysis to
categorize the two scores of Skindex-17 (Table S4). The
scores of the psychosocial subscale varied between 1 and 26,
which could consist of three distinct distributions with mean
scores of about 2, 7, and 15, which were subsequently
categorized as having little (o5), moderate (5–9), and high
(49) impact on patients’ lives. The total symptoms score
could be dichotomized; patients who reported 5 or more on
this subscale could be categorized as experiencing a lot of
symptoms.
DISCUSSION
Skindex-17 vs Skindex-29
The Skindex-17 (Appendix S2) is derived from Skindex-29,
which is a well-designed and extensively studied HRQOL
instrument in dermatology. However, a Rasch reduced
version of Skindex-29 has practical advantages such as
decreased response burden and theoretical advantages such
as fit to an item response theory model. This transition from
representational (Stevens, 1946) to fundamental measure-
ment theory has multiple implications, such as that it ensures
unidimensionality, additivity, response order, DIF, and speci-
fic objectivity (Michell, 1997, 2003), and is considered to be
the new standard in psychometric methodology (McHorney,
1997; Michell, 2003). Although the retained items with
response categories in Skindex-17 are identical to the original
items, the scores should be collapsed into a 3-point scoring
system and the three subscales with an overall score have
been replaced by two subscales (psychosocial and symptoms)
with separate summing scores. In HRQOL assessments, it is
not uncommon to report multiple summing scores without a
total overall score (Hemingway et al., 1997; Houssien et al.,
1997) or to collapse scoring categories (Piccinelli et al., 1993;
Nijsten et al., 2006). Collapsing or reducing response
categories does not necessarily decrease the precision of an
HRQOL instrument (Piccinelli et al., 1993; De Jong et al.,
1997; ). The fact that the subscales of Skindex-17 reflected
more than 85% of the total variance of its counterparts of
Skindex-29 and that the correlations between the (sub)scales
was excellent suggest that deleting 12 items from Skindex-29
has resulted in a minimal loss of information. Moreover, this
reduction process did not substantially alter the excellent
psychometric properties of the original Skindex-29 (Chren
et al., 1997).
Comparing Skindex-16, which focuses on degree of bother
rather than frequency and is shortened based on patients’
perspectives (Chren et al., 2001), with Skindex-17, which is
the result of the statistical model, is of interest. Of the 12
items that remained relatively the same in Skindex-16 and
-29, nine items (75%) were both in Skindex-17 and -16.
Overall, a simple and preliminary comparison suggests
that these different reduction approaches (patient-based vs
mathematics-based) may result in similar reduced instru-
ments. Nevertheless, it would be interesting to compare the
outcomes of Skindex-17 and -16 in a population to study
these different ways of model selection in more detail.
Effect of external factors on HRQOL impairment
It has been demonstrated in the development of new HRQOL
for psoriasis and atopic dermatitis that DIF across demo-
graphic variables is an important consideration (McKenna
et al., 2003; Whalley et al., 2004; Nijsten et al., 2005, 2006)
and Skindex-17 is the first dermatology-specific instrument
to address the issue of response differences of patients in
functions of age, gender, diagnosis, and disease severity. Of
interest, none of the items of Skindex-17 showed significant
DIF for education and marital status (data not shown). Of
importance for a dermatology-specific HRQOL instrument is
that the items of Skindex-17 psychosocial subscale behave
similarly among patients with different diagnoses even with
varying levels of clinical disease severity. For example, a
psoriasis patient who has little HRQOL impairment responds
in a similar way to each of the items as a vitiligo patient with
the same level of impairment. In contrast to the psychosocial
subscale, the scores of the symptoms subscale should be
compared between different skin diseases cautiously because
symptoms scores depend on patients’ disease. Intuitively, it is
not surprising that items that assess skin symptoms behave
differently among different skin conditions. For example, DIF
analyses demonstrated that individuals with seborrheic
dermatitis were significantly more frequently bothered by
water but significantly less by bleeding compared to patients
with psoriasis or acne, despite the same level of HRQOL
impairment (Po0.001). Ideally, the symptoms subscale
should only be used to compare the impact of symptoms
within and not between skin diseases. Although to a lesser
extent than for diagnosis, the scores of the symptoms subscale
should be compared with caution across gender because
women are more likely to give higher scores, but not signi-
ficantly, than men for most symptoms items (Table S2).
Measurement of (very) limited HRQOL impairment in
‘‘benign’’ skin conditions such as nevi and (senile) warts
remains challenging, because generic and dermatology-
specific instruments may not be sensitive enough. Despite
the floor effect of 9 of 12 psychosocial items and three of five
symptoms items (data not shown) among nevi patients and
that none of the respondents with nevi reported ‘‘often’’ or
‘‘all the time’’ for any of the 17 items (except for item 21,
‘‘embarrassed’’), Skindex-17 was able to select those who
indicated at least moderate psychosocial impairment and
those with more than a few symptoms (12 and 5% of the nevi
patients, respectively). Re-doing the Rasch analysis in sample
1 without the 49 nevi patients resulted in exactly the same
item retention with adequate fit to the model (P¼0.25,
Cronbach’s a¼ 0.93). In the future, it would be interesting to
study the effect of cultural background on the HRQOL tools
that are used in international collaborations (Bullinger
et al., 1993; Tennant et al., 2004b). In addition to static
assessments, change in HRQOL impairment may also depend
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on external factors such as age, education, and marital status
(Hemingway et al., 1997; Unaeze et al., in press). Therefore,
the effect of patients’ characteristics should be carefully
evaluated before comparing HRQOL scores of different
patient populations, as is done in clinical trials or surveys,
especially if the used tool has not been tested for DIF
previously.
Sensitivity analyses
To test whether combining the functioning and emotion
subscales did affect our findings, we re-did the Rasch
analyses accepting the three dimensions of Skindex-29 and
analyzing each separately and combined. Neither approach
improved the reduction process of this instrument (data not
shown). For example, the emotion subscale did not fit the
overall Rasch model (Po0.0001), and even after shortening it
to three items based on item fit and DIF its overall fit to the
Rasch model remained very poor (P¼0.004). Alternatively,
Rasch analyses of the three subscales combined resulted in
significant DIF for diagnosis (Pp0.006) for six out of seven
symptoms-related items. These a posteriori Rasch analyses
demonstrate how the selection of the included items affects
the result because item fit and DIF are determined by the total
amount of underlying construct (i.e., HRQOL impairment
due to skin conditions), which entirely depends on the items
selected. This underlying methodology also plays a role in the
order of deleting items that demonstrate significant item misfit
and/or DIF because it may change the outcome substantially.
CONCLUSION
The Skindex-17 is a Rasch-reduced version of Skindex-29 that
overcomes some of the fundamental issues in measurement.
This reduced questionnaire behaved psychometrically very
well in this study population and may be a valuable tool in
the measurement of patient-based outcomes in dermatology,
but its psychometric properties and clinical value should first
be tested in other populations.
MATERIALS AND METHODS
Participants and settings
The design of the study included the characteristics of its participants
who were all aged 18 or more and attending the outpatient clinics of
dermatology and dermatological surgery of a large Italian dermato-
logical hospital on predetermined days. More than 80% of the
patients are referred to this institution by their general practitioner.
After signing an informed consent, the Italian version of Skindex-29,
which was created according to the guidelines for the cross-cultural
adaptation of the HRQOL measures (Guillemin et al., 1993) and
validated (Abeni et al., 2001, 2002), was administered (Appendix
S1). After the visit, the physician registered the diagnosis and rated
the severity of the skin condition by answering the question ‘‘In your
experience, among all patients you have seen with this condition,
how severe is this patient’s condition?’’, which was defined as the
physician global assessment. The possible responses were: very
mild, mild, moderate, severe, and very severe. The 2,242
dermatological patients presented various dermatological diagnoses.
However, in the present study, we restricted the analyses to 454
patients whose diagnoses were part of the following diagnostic
groups: (1) acne; (2) psoriasis; (3) seborrheic dermatitis; (4) alopecia
areata; (5) vitiligo; and (6) nevi. These diagnostic groups were
selected because they represent relatively homogenous groups
of diagnoses, may be associated with comparable HRQOL impair-
ment, and consisted of at least 25 patients. As there were relatively
more patients with nevi, we randomly selected 100 of the 258
individuals whose major concern was nevi. Subsequently, the 454
subjects were divided into two groups. Both selection procedures
used the random number generator method. The sampling of
two smaller subsets was done because the w2 statistics used in the
Rasch model are very sensitive to the sample size (if n is large, even
slight deviations from unidimensionality may be statistically
significant) (Tesio, 2003) and it enabled us to compare the findings
in both samples.
Age was categorized into three levels (o45; 45–64; and X65
years). The 5-point physician global assessment re-grouped into four
levels ((1) very mild; (2) mild; (3) moderate; and (4) severe and very
severe), because the very severe score was reported in only 1% of
the patients. Ethical approval was granted by the institutional review
board and the study was carried out in compliance with the
Declaration of Helsinki Principles.
Statistics
Rasch analysis. Statistical analyses have been described in
detail previously (Nijsten et al., 2005, 2006). The same procedure
of Rasch analysis was followed for samples 1 and 2. To ensure
a homogeneous and ordered scoring system, the threshold order
was examined for each of the 29 items. Owing to practical reasons,
the scoring categories were not altered for each item separately,
but according to the most optimal ordering for the vast majority of
the items.
Based on a cluster analysis that included Skindex-29 (Sampogna
et al., 2004) that showed a high correlation between functional and
emotional subscales, we combined these two subscales (psychoso-
cial subscale), and analyzed them separately from the symptoms
subscale (21 and 7 items, respectively). As the data of the two
subscales of sample 1 and 2 did not fit the rating scale model
(Po0.001), we used the unrestricted Rasch model for all analyses. In
the Rasch model, individual item misfit was present if an item
showed a significant w2 statistic or a large positive (42.5) or negative
(o2.5) standardized residual. To ensure that responses to
individual items were unaffected by external factors (age, gender,
diagnosis, and disease severity) to the measurement tool, DIF
analyses were performed (Angoff, 1993). For the symptoms subscale,
DIF for diagnosis was not assessed because preliminary analyses
showed that all symptom-related items had significant DIF for
diagnosis (Po0.0001), except items 1 and 26 (P¼ 0.38 and 0.05,
respectively). Overall fit of the data to the model was assessed using
item–trait interaction.
To confirm the unidimensionality of the retained items that fitted
the Rasch model, a principal component analysis was performed. If
the first factor after discounting the ‘‘Rasch factor’’ accounted for
o40% of the variance, the scale was assumed to be unidimensional.
Classical psychometric features of Skindex-17. To test the
validity of Skindex-17, we examined the relation between the
original and the short version of the Skindex using Pearson’s
correlation coefficients (r) and the adjusted R2 in a linear regression
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model. Construct validity was assessed by testing the assumption
that patients with inflammatory dermatoses such as psoriasis and
acne would have higher scores than patients with nevi. In addition,
multiple classical test theory -based psychometric features of
Skindex-17 and its items were studied, including response distribu-
tion, item–rest correlation, item discriminant validity, item complex-
ity, and Cronbach’s a’s (Nijsten et al., 2005, 2006). A principal
component analysis followed by oblique rotation was performed to
test the proposed subscaling of Skindex-17. Factors with eigenvalues
of 1 or more were retained.
Categorization of scores. The scores of the new Rasch reduced
psychosocial and symptoms subscale of the Skindex were entered
into a mixture analysis using computer-assisted mixture analysis
(Haughton, 1997). This statistical method detects whether multiple,
distinct subdistributions are present in the distribution of the scores
of all the individuals and would, therefore, facilitate the interpreta-
tion of the new scores. We used the same procedure as described
previously for the categorization of another HRQOL instrument
(Nijsten et al., 2006). In brief, we estimated the weights for the
maximum number of grid points suggesting Poisson distributions,
which were subsequently used as starting values for the expecta-
tion–maximization algorithm. Then, a much smaller number of
weights and support points were computed with nonparametric
maximum likelihood estimations of 1 and by combining support
points that are very close to each other or have very low weights. The
support points and weights that remained were then entered in a
fixed mixture to classify each observation in one of the different
mixture components using posterior probabilities.
All statistical tests were two sided. Significance was assessed at
an a level o0.05, with the exceptions outlined above. Stata version
7.0 (Stata Corp., College Station, TX) was used to estimate
Cronbach’s a, the correlation coefficients, and the principal axis
analyses. SPSS version 10.0 for Windows (SPSS Inc., Chicago, IL)
was used to randomize the sample in two groups. Rasch analyses
were performed using RUMM2020 (RUMM Laboratory Pty Ltd,
Perth, Australia). To categorize the Rasch version of the Skindex,
computer-assisted mixture analysis 2.0 was used (Boehning and
Schlattmann, 2005).
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